INTERNATIONAL PATENT: LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN, IN VERTRETUNG DES FREISTAATES BAYERN FILES APPLICATION FOR "ANILINE-BASED MODULATORS OF THE NUCLEAR RECEPTOR TLX (NR2E1)"

GENEVA, Nov. 24 -- LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN, IN VERTRETUNG DES FREISTAATES BAYERN (Geschwister-Scholl-Platz 180539 Munchen) filed a patent application (PCT/EP2025/063165) for "ANILINE-BASED MODULATORS OF THE NUCLEAR RECEPTOR TLX (NR2E1)" on May 14, 2025. With publication no. WO/2025/238054, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MERK, Daniel (Department of PharmacyLudwig-Maximilians-Universitat MunchenButenandtstraBe 5-1381377 Munchen), HANK, Emily C. (Department of PharmacyLudwig-Maximilians-Univer...